Review Article of American Journal of Dermatological Research and Reviews
Vitiligo Treated by Soaking in an Earth Pond Containing KELEA Activated Water
John Martin1* and Shera Sandwell1
1Institute of Progressive Medicine, 1634 Spruce Street, South Pasadena CA 91030 USA.
Vitiligo completely regressed in two patients who spent several hours for each of three consecutive days in a pond that contains water with a heightened quantity of a non-thermal activity attributed to a natural force called KELEA (Kinetic Energy Limiting Electrostatic Attraction). KELEA is further defined as the source of cellular energy, which comprises the alternative cellular energy (ACE) pathway. The ACE pathway differs from the cellular energy obtained from food metabolism. It is expressed as an added dynamic (kinetic) quality of the body’s fluids. The body utilizes the ACE pathway in both chemical and electrical cellular reactions, including the recovery and regenerative processes following cellular damage. The ACE pathway supports the higher levels of brain functioning including the likelihood of improving upon the presumed KELEA receiving capacity of the brain. The ACE pathway can also limit the triggering and maintenance of the inflammatory response. Each of these activities is presumably involved in the clinical regression of the vitiligo in the two patients. Enhancing the ACE pathway may provide an effective therapeutic approach for many patients with vitiligo.
Keywords: Vitiligo; Stealth adapted viruses; Alternative cellular energy; ACE pathway; Kinetic energy limiting electrostatic attraction
How to cite this article:
W. John Martin, Shera Sandwell. Vitiligo Treated by Soaking in an Earth Pond Containing KELEA Activated Water.American Journal of Dermatological Research and Reviews, 2020; 3:32. DOI: 10.28933/ajodrr-2020-08-0105
1. Bergqvist C, Ezzedine K (2020) Vitiligo: A review. Dermatology, 10: 1-22. doi:10.1159/0005 06103.
2. Marçon CR, Maia M (2019). Albinism: epidemiology, genetics, cutaneous characterization, psychosocial factors. Anais brasileiros de dermatologia, 94(5): 503–520.
3. Krüger C, Schallreuter K U (2012). A review of the worldwide prevalence of vitiligo in children/adolescents and adults. International Journal of Dermatology, 51(10): 1206–1212. doi: 10.1111/j.1365-4632.2011.05377.x.
4. Solano F (2014) Melanins: Skin pigments and much more—Types, structural models, bio-logical functions, and formation routes. New J Science Article ID 498276, doi.10.1155/2014/498 276.
5. Plonka PM, Grabacka M (2006) Melanin synthesis in microorganisms–biotechnological and medical aspects. Acta Biochim Pol. 53(3): 429-43.
6. Vasileiou T, Summerer L (2020) A biomimetic approach to shielding from ionizing radiation: The case of melanized fungi. PLoS ONE, 15(4): e0229921.
7. Zou Y, Zhao Y (2015) Properties of melanin from black tea leaves. ScienceAsia, 41: 400–404 doi: 10.2306/scienceasia1513-1874.2015.
8. Riley PA (1997) Melanin. Int J Biochem Cell Biol. 29(11):1235-9.
9. Quevedo Jr WC, Fitzpatrick TB, Jimbow K (1985) Human skin color: origin, variation and significance. Journal of Human Evolution, 14(1): 43–56.
10. Hu DN, Simon JD, Sarna T (2008) Role of ocular melanin in ophthalmic physiology and pathology. Photochem Photobiol.84(3): 639-44. doi: 10.1111/j.1751-1097.2008.00316.x.
11. Goldgeie MH, Klein LE, Klein-Angerer S, et al. (1984) The distribution of melanocyte in the leptomeninges of the human brain. J Invest Dermatol, 82: 235–238.
12. Zecca L, Tampellini D, Gerlach M, et al. (2001). Substantia nigra neuromelanin: structure, syn-thesis, and molecular behaviour. Molecular Pathology: MP 54(6): 414–418.
13. Gibb W R, Lees A J (1991). Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 54(5): 388–396. https://doi.org/10.1136/jnnp.54.5.388
14. Rahimi H, Mozafari N, Bastaninejad S, et al. (2019). Hearing status in patients with vitiligo. Clinical, Cosmetic and Investigational Dermatology, 12: 445–450.
15. Tobin DJ, Swanson NN, Pittelkow MR, et al. (2000) Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol, 191: 407–16.
16. Moellmann G, Klein-Angerer S, Scollay DA, et al. (1982) Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol, 79(5): 321–30.
17. Manga P, Elbuluk N, Orlow S J (2016). Recent advances in understanding vitiligo. F1000Research, 5, F1000 Faculty Rev: 2234
18. Sharquie KE, Mehenna SH, Naji AA, et al. (2004) Inflammatory changes in vitiligo: Stage I and II depigmentation. Am J Dermatopathol. 26(2): 108–12.
19. Wang Y, Li S, Li C (2019). Perspectives of new advances in the pathogenesis of vitiligo: From oxidative stress to autoimmunity. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 25: 1017–1023. https://doi.org/10.12659/MSM.914898
20. Harris J E (2016). Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo. Immunological Reviews, 269(1): 11–25.
21. Ding GZ, Zhao WE, Li X, et al. (2015) A comparative study of mitochondrial ultrastructure in melanocytes from perilesional vitiligo skin and perilesional halo nevi skin. Arch Dermatol Res. 307(3): 281-9. doi: 10.1007/s00403-015-1544-4.
22. Curzytek K, Pietowska J, Spiewak R (2007) Drug-induced vitiligo: A meta-analysis of reported cases. Allergy (Suppl 83: XXVI Con-gress of the European Academy of Allergology and Clinical Immunology) 62: 447.
23. Toosi S, Orlow S J, Manga P (2012). Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. Journal of Investigative Dermatology, 132(11): 2601–2609. https://doi. org/10.1038/jid.2012.181.
24. Chan S W (2014). The unfolded protein response in virus infections. Frontiers in Microbiology, 5: 518.
25. Dwivedi M, Laddha NC, Begum R (2018) Viral causes of vitiligo: A new perspective for vitiligo pathogenesis. Virology & Immunology Journal 2(8): 000181.
26. Simons RE, Zevy DL, Jafferany M (2020) Psychodermatology of Vitiligo: Psychological impact and consequences. Dermatol Ther, e13418. doi: 10.1111/dth.13418.
27. Grimes P E, Miller M M (2018). Vitiligo: Patient stories, self-esteem, and the psychological burden of disease. International Journal of Women’s Dermatology, 4(1), 32–37.
28. Spritz R A, Andersen G H (2017). Genetics of vitiligo. Dermatologic Clinics, 35(2): 245–255. https://doi.org/10.1016/j.det.2016.11.013
29. Zubair R, Hamzavi IH (2020) Phototherapy for Vitiligo Dermatol Clin, 38(1): 55-62. doi: 10.1016/j.det.2019.08.005.
30. Bae J M, Jung H M, Hong B Y, et al. (2017). Phototherapy for Vitiligo: A Systematic Review and Meta-analysis. JAMA Dermatology, 153(7) : 666–674. https://doi.org/10.1001/jamadermatol.2017.0002
31. Westerhof W, Nieuweboer-Krobotova L (1997) Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol, 133(12):1525-1528.
32. Gianfaldoni S, Tchernev G, Lotti J, et al. (2018). Unconventional treatments for vitiligo: Are they (un) satisfactory? Macedonian Journal of Medical Sciences, 6(1): 170–175.
33. Phan K, Phan S, Shumack S, Gupta M (2020) Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis. J Dermatolog Treat. 1-5. doi:10.1080/09546634.2020.17356 15.
34. Zokaei S, Farhud DD, Keykhaei M, et al. (2019) Cultured epidermal melanocyte transplantation in vitiligo: a review article. Iran J Public Health, 3: 388-399.
35. Khunger N, Kathuria S D, Ramesh V (2009). Tissue grafts in vitiligo surgery – past, present, and future. Indian Journal of Dermatology, 54(2): 150–158.
36. Frisoli ML, Essien K, Harris JE (2020) Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol. 38: 621-648. doi:10.1146/ annurev-immunol-100919-023531.
37. Martin WJ (2014) Stealth Adapted Viruses; Alternative Cellular Energy (ACE) & KELEA Activated Water: A New Paradigm of Healthcare. Author House Bloomington IN p321
38. Martin WJ (2014) Stealth adaptation of viruses: Review and updated molecular analysis on a stealth adapted African green monkey simian cytomegalovirus (SCMV). J Hum Virol Retrovirol, 1(4): 00020. doi:10.15406/jhvrn.2014.01.0
39. Martin WJ (2015) Stealth adapted viruses – Possible drivers of major neuropsychiatric illnesses including Alzheimer’s disease. J Neurol Stroke 2(3): 00057.
40. Martin WJ (2015) Is the brain an activator of the alternative cellular energy (ACE) pathway? International J Complementary & Alternative Medicine 1(1): 00002.
41. Martin WJ (2020) Enhancing the alternative cellular energy (ACE) pathway with KELEA activated water as therapy for infectious diseases. Infect Disord Drug Targets. 20: Published online ahead of print, Feb. 10. doi:10.2174/18715265206620 0211115111
42. Martin WJ (2017) The many biological functions of the alternative cellular energy (ACE) path-way. International J Complementary & Alternative Medicine 7(5): 00237.
43. Martin WJ (2017) Tissue regeneration without scarring achieved by enhancing the alternative cellular energy (ACE) pathway. J Cosmetics, Dermatological Sciences and Applications 7(1): 82-98.
44. Martin WJ (2016) The ACE pathway in comparison to the immune system in the defense against infectious diseases. J Human Virology & Retrovirology. 3(5): 00124. doi: 10.15406/jh vrv.2016.04.00124
45. Martin WJ (2016) Deconstructing medicine: The alternative cellular energy pathway. British J Medicine & Medical Research, 11(8): 1-6.
46. Martin WJ (2016) Insufficiency of cellular energy (ICE). The basis for many illnesses potentially correctable using KELEA activated water. International J Complementary & Alter-native Medicine 4(1): 00106.
47. Martin WJ (2017) Hyper-excitability followed by functional quiescence in neuronal cells caused by insufficient cellular energy (ICE): Treatable by enhancing the alternative cellular energy (ACE) pathway. World J Neuroscience 7(3): 257-266.
48. Martin WJ (2017) Insufficiency of cellular energy (ICE) may precede neurodegeneration in Alzheimer’s disease and be treatable via the alternative cellular energy (ACE) pathway. Advances in Alzheimer’s Disease 6(1): 1-12.
49. Martin WJ (2017) Insufficiency of cellular energy (ICE) from the alter- native cellular energy (ACE) pathway limiting the specialized functions of neuronal cells. Int J Complement Alt Med., 4: 00112.
50. Brenner S (2014) Parkinson’s disease may be due to failure of melanin in the Substantia Nigra to produce molecular hydrogen from dissociation of water, to protect the brain from oxidative stress. Med Hypotheses. 82(4): 503. doi:10.10 16/j.mehy.2014.01.013.
51. Enochs WS, Sarna T, Zecca L, et al. (1994) The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson’s disease: a hypothesis. J Neural Transm Park Dis Dement Sect. 7(2): 83-100.
52. Youdim MB, Ben-Shachar D, Riederer P (1994)The enigma of neuromelanin in Parkinson’s disease substantia nigra. J Neural Transm Suppl. 43:113-22.
CC BY 4.0
This work and its PDF file(s) are licensed under a Creative Commons Attribution 4.0 International License.